Whilst it may not be a huge deal, we thought it was good to see that the OrganoClick AB (publ) (STO:ORGC) Co-founder & CEO, Marten Hellberg, recently bought kr475k worth of stock, for kr3.39 per share. However, it only increased their shares held by 1.9%, and it wasn't a huge purchase by absolute value, either.
OrganoClick Insider Transactions Over The Last Year
Notably, that recent purchase by Marten Hellberg is the biggest insider purchase of OrganoClick shares that we've seen in the last year. That means that even when the share price was higher than kr3.44 (the recent price), an insider wanted to purchase shares. Their view may have changed since then, but at least it shows they felt optimistic at the time. We always take careful note of the price insiders pay when purchasing shares. It is encouraging to see an insider paid above the current price for shares, as it suggests they saw value, even at higher levels. Marten Hellberg was the only individual insider to buy shares in the last twelve months.
Marten Hellberg bought 160.00k shares over the last 12 months at an average price of kr4.28. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.
Does OrganoClick Boast High Insider Ownership?
Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Insiders own 24% of OrganoClick shares, worth about kr75m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.
What Might The Insider Transactions At OrganoClick Tell Us?
It is good to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. But on the other hand, the company made a loss during the last year, which makes us a little cautious. Insiders likely see value in OrganoClick shares, given these transactions (along with notable insider ownership of the company). In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing OrganoClick. To assist with this, we've discovered 4 warning signs that you should run your eye over to get a better picture of OrganoClick.
But note: OrganoClick may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.